share_log

藥明生物:董事名單與其角色及職能

WUXI BIO: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

香港交易所 ·  Apr 1 19:14
Summary by Futu AI
药明生物技术有限公司(股份代號:2269),即WUXI BIO,於2024年3月31日公布了其董事會成員名單,包括執行董事、非執行董事以及獨立非執行董事。公司首席執行官為陳智勝博士,而董事長為李革博士。此外,董事會下設有五個委員會,包括審核委員會、薪酬委員會、提名委員會、決策委員會以及環境、社會及管治委員會,並明確列出了各委員會的主席及成員。該公告顯示了药明生物對公司治理結構的透明度,並為投資者提供了公司領導層的最新資訊。
药明生物技术有限公司(股份代號:2269),即WUXI BIO,於2024年3月31日公布了其董事會成員名單,包括執行董事、非執行董事以及獨立非執行董事。公司首席執行官為陳智勝博士,而董事長為李革博士。此外,董事會下設有五個委員會,包括審核委員會、薪酬委員會、提名委員會、決策委員會以及環境、社會及管治委員會,並明確列出了各委員會的主席及成員。該公告顯示了药明生物對公司治理結構的透明度,並為投資者提供了公司領導層的最新資訊。
PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. (STOCK CODE: 2269), I.E. WUXI BIO, ANNOUNCED ON MARCH 31, 2024 ITS LIST OF BOARD MEMBERS, INCLUDING EXECUTIVE DIRECTORS, NON-EXECUTIVE DIRECTORS AND INDEPENDENT NON-EXECUTIVE DIRECTORS. THE CEO OF THE COMPANY IS DR. CHAN CHI SHENG AND THE CHAIRMAN IS DR. LI KEG. In addition, there are five committees under the Board of Directors, including the Audit Committee, the Remuneration Committee, the Nominating Committee, the Decision Committee and the Environment, Social and Governance Committees, with a clear list of the chairmen and members of each committee. The announcement demonstrates the transparency of the company's governance structure and provides investors with updates on the company's leadership.
PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. (STOCK CODE: 2269), I.E. WUXI BIO, ANNOUNCED ON MARCH 31, 2024 ITS LIST OF BOARD MEMBERS, INCLUDING EXECUTIVE DIRECTORS, NON-EXECUTIVE DIRECTORS AND INDEPENDENT NON-EXECUTIVE DIRECTORS. THE CEO OF THE COMPANY IS DR. CHAN CHI SHENG AND THE CHAIRMAN IS DR. LI KEG. In addition, there are five committees under the Board of Directors, including the Audit Committee, the Remuneration Committee, the Nominating Committee, the Decision Committee and the Environment, Social and Governance Committees, with a clear list of the chairmen and members of each committee. The announcement demonstrates the transparency of the company's governance structure and provides investors with updates on the company's leadership.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.